Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Loading
Home›
Research›
Investment Firms›
Refactor Capital
AddedFeb 13, 2024
UpdatedJul 16, 2026
Refactor Capital

Refactor Capital

Operating

Refactor Capital: A seed-stage venture capital firm investing in solutions for fundamental human health issues.

Location
Burlingame, CA, US
Founded
2016
Firm
Compare
Portfolio
Employees
Website

Investments

Orchid
Orchid

Total Raised

$16.5M

Rounds

3

Seed$12MDecember 2023
Seed$4.5MApril 2021
Hyfé
Hyfé

Total Raised

$11M

Rounds

2

Seed$9MJune 2023
Modulo Bio
Modulo Bio

Total Raised

$8M

Rounds

1

Seed$8MJune 2023
Macro Oceans
Macro Oceans

Total Raised

$5M

Rounds

1

Seed$5MApril 2023
Melonfrost
Melonfrost

Total Raised

$7M

Rounds

2

Seed$7MJanuary 2023
Parallel Bio
Parallel Bio

Total Raised

$4.6M

Rounds

2

Seed$4.3MDecember 2022
Solugen
Solugen

Total Raised

$642.2M

Rounds

9

Series D$200MOctober 2022
Series C$357MSeptember 2021
YourChoice Therapeutics
YourChoice Therapeutics

Total Raised

$16.7M

Rounds

6

Series A$15MJuly 2022
Fyto
Fyto

Total Raised

$33M

Rounds

4

Series A$15MJuly 2022
Ness
Ness

Total Raised

$15.5M

Rounds

1

Seed$15.5MMay 2022
Mori
Mori

Total Raised

$82.3M

Rounds

7

Series B$50MMarch 2022
Series B$16MApril 2021
64x Bio
64x Bio
Series A

Total Raised

$59.6M

Rounds

3

Series A$55MJanuary 2022
Seed$4.5MNovember 2020
Mythic Therapeutics
Mythic Therapeutics

Total Raised

$126.6M

Rounds

3

Series B$103MDecember 2021
Ophelia
Ophelia

Total Raised

$67.7M

Rounds

3

Series B$50MDecember 2021
Series A$15MApril 2021
Knowde
Knowde

Total Raised

$90.8M

Rounds

5

Series B$72MAugust 2021
Brave Care
Brave Care
Series B

Total Raised

$41.6M

Rounds

4

Series A$10MApril 2021
Astranis
Astranis
Series E

Total Raised

$853.6M

Rounds

9

Series C$250MApril 2021
Spora Health
Spora Health

Total Raised

$4.2M

Rounds

4

Seed$3MMarch 2021
Rubedo Life Sciences
Rubedo Life Sciences

Total Raised

$13.4M

Rounds

5

Seed$12MDecember 2020
Curative
Curative

Total Raised

$8M

Rounds

2

Seed$8MSeptember 2020